project id: TCGA-COAD; case submitter id: TCGA-AA-A02Y; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 7.6; spectrophotometer method: UV Spec; age at index: 73; days to birth: -26724; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1934; age at diagnosis: 26724; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1216.0; icd 10 code: C18.0; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cecum; synchronous malignancy: No; tissue or organ of origin: Cecum; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1128; days to sample procurement: 0; initial weight: 490.0; portion submitter id: TCGA-AA-A02Y-01A-43; percent necrosis: 1.0; percent neutrophil infiltration: 1.0; percent stromal cells: 10.0;